J D Bitran|J E Ultmann - JoVE Visualize

Showing results (111-120 of 125) with videos related to

Pageof 13

Sort By:

Seminars in Oncology|August 1, 1995

Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancerP C Hoffman, S A Krauss, L C Drinkard, et al.

Seminars in Oncology|October 1, 1994

A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study designE E Vokes, L C Drinkard, B L Samuels, et al.

Cancer|July 1, 1984

Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experienceP J Madej, J D Bitran, H M Golomb, et al.

Cancer Treatment Reports|March 1, 1978

Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinomaJ D Bitran, R K Desser, T DeMeester, et al.

American Journal of Clinical Oncology|June 1, 1986

Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypesK S Albain, P C Hoffman, A G Little, et al.

Journal of Surgical Oncology|February 1, 1982

Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breastC M Shapiro, D Schifeling, J D Bitran, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998

Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancerG F Fleming, J W Kugler, P C Hoffman, et al.

Cancer|July 1, 1979

Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.

Blood|November 1, 1987

Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lungM J Ratain, L S Kaminer, J D Bitran, et al.

Bone Marrow Transplantation|June 13, 2000

Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trialS Yanovich, P Mitsky, K Cornetta, et al.

Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:

Pageof 13

Seminars in Oncology|August 1, 1995

Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancerP C Hoffman, S A Krauss, L C Drinkard, et al.

Seminars in Oncology|October 1, 1994

A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study designE E Vokes, L C Drinkard, B L Samuels, et al.

Cancer|July 1, 1984

Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experienceP J Madej, J D Bitran, H M Golomb, et al.

Cancer Treatment Reports|March 1, 1978

Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinomaJ D Bitran, R K Desser, T DeMeester, et al.

American Journal of Clinical Oncology|June 1, 1986

Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypesK S Albain, P C Hoffman, A G Little, et al.

Journal of Surgical Oncology|February 1, 1982

Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breastC M Shapiro, D Schifeling, J D Bitran, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998

Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancerG F Fleming, J W Kugler, P C Hoffman, et al.

Cancer|July 1, 1979

Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.

Blood|November 1, 1987

Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lungM J Ratain, L S Kaminer, J D Bitran, et al.

Bone Marrow Transplantation|June 13, 2000

Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trialS Yanovich, P Mitsky, K Cornetta, et al.

Pageof 13